Advertisement

International Journal of Clinical Pharmacy

, Volume 33, Issue 2, pp 237–245 | Cite as

How do pharmacists respond to complaints of acute insomnia? A simulated patient study

  • Carly Kippist
  • Keith Wong
  • Delwyn Bartlett
  • Bandana SainiEmail author
Research Article

Abstract

Objective It is known that many people with insomnia choose to self medicate and present at community pharmacies, particularly in cases of acute insomnia. The objective of this study is to investigate how community pharmacists respond to complaints of acute insomnia from people who seek self treatment and determine the factors affecting this response. Setting Community pharmacies in New South Wales, Australia. Method A simulated patient study was conducted in 100 randomly selected pharmacies located in Newcastle and Sydney, Australia. A standardized scenario of acute sleep onset insomnia and a scoring system was used in each pharmacy. Main outcome measures Main outcome measures included supply/non supply of an over the counter sleep aid to the simulated patient, and scores for pharmacists for skills in eliciting information prior to supply of medication (Pre Supply Score), counseling about medication (Supply Score), or about sleep (Sleep Score). Results Of the 100 pharmacies, upon simulated patient presentation, 96% supplied a product, the remaining 4% referred to a physician. Non-pharmacological advice was provided in 42%. Pharmacists scored highly on advice provided with supply of a medication (Supply scores/4, 3.1 ± 0.9), but lower on skills in eliciting information prior to supply (Pre-supply score/8, 3.6 ± 1.9) and sleep related counselling (Sleep Score/9, 2.1 ± 1.7). Lower estimated pharmacist age, being in a chain type pharmacy, and having a visible symbol of quality accreditation were found to significantly improve (P < 0.05 the Sleep Score outcome. Lower estimated pharmacist age as also significantly associated with higher Supply Score (P < 0.05); whilst both lower estimated age an visible quality assurance signage were associated with higher Pre-Supply scores (P < 0.05). Conclusion The results of this study suggest that many pharmacists are responding appropriately to complaints of sleeplessness in terms of eliciting insomnia type and counseling about medicines use. However more education for pharmacists would help to further promote good sleep health, and address behaviors including reliance on medicines taking that can progressively worsen insomnia.

Keywords

Australia Counseling Insomnia Non-prescription medicines Over-the-counter (OTC) medicines Simulated patient 

Notes

Acknowledgments

The author would like to acknowledge Penelope Redman, Grace Shoukry and Kaye Kippist for their assistance in conducting data collection.

Funding

None declared. The project reported in this paper did not receive any financial assistance from any sources; and was conducted as part of a BPharmacy final year undergraduate honors project.

Conflicts of interest

None.

References

  1. 1.
    Bhat A, Shafi F, Solh A. Pharmacotherapy of insomnia. Expert Opin Pharmacother. 2008;9(3):351–62.PubMedCrossRefGoogle Scholar
  2. 2.
    Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31(4):473–80.PubMedGoogle Scholar
  3. 3.
    Passarella S, Duong MT. Diagnosis and treatment of insomnia. Am J Health Syst Pharm. 2008;65(10):927–34.PubMedCrossRefGoogle Scholar
  4. 4.
    Roth T, Roehrs T, Pies R. Insomnia: pathophysiology and implications for treatment. Sleep Med Rev. 2007;11(1):71–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Sivertsen B, Krokstad S, Mykletun A, Overland S. Insomnia symptoms and use of health care services and medications: the HUNT-2 study. Behav Sleep Med. 2009;7(4):210–22.PubMedCrossRefGoogle Scholar
  6. 6.
    Morin CM, LeBlanc M, Daley M, Grégoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123–30.PubMedCrossRefGoogle Scholar
  7. 7.
    Taylor DJ, Lichstein KL, Durrence H, Riedel BW, Bush AJ. Epidemiology of insomnia, depression, and anxiety. Sleep. 2005;28(11):1457–64.PubMedGoogle Scholar
  8. 8.
    Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39(6):411–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Sivertsen B, Overland S, Neckelmann D, et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am J Epidemiol. 2006;163(11):1018–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J, Baillargeon L. Insomnia and its relationship to health-care utilization, work absenteeism, productivity, and accidents Sleep Med. doi: 10.1016/j.sleep.2008.04.005.
  11. 11.
    Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Predictors of primary medical care consultation for sleep disorders. Sleep Med. 2008;9(8):857–64.PubMedCrossRefGoogle Scholar
  12. 12.
    Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Sleep health New South Wales: chronic sleep restriction and daytime sleepiness. Intern Med J. 2008;38(1):24–31.PubMedGoogle Scholar
  13. 13.
    Drake CL, Roehrs T, Roth T. Insomnia causes, consequences, and therapeutics: an overview. Depress Anxiety. 2003;18(4):163–76.PubMedCrossRefGoogle Scholar
  14. 14.
    Buysse DJ. Chronic insomnia. Am J Psychiatry. 2008;165(6):678–86.PubMedCrossRefGoogle Scholar
  15. 15.
    Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T. Tolerance to daytime sedative effects of H1 antihistamines. J Clin Psychopharmacol. 2002;22(5):511–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Leybishkis B, Fasseas P, Ryan K. Doxylamine overdose as a potential cause of rhabdomyolysis. Am J Med Science. 2001;322(1):48–9.CrossRefGoogle Scholar
  17. 17.
    Thomas A, Nallur DG, Jones N, Deslandes PN. Diphenhydramine abuse and detoxification: a brief review and case report. J Psychopharmacol. 2009;23(1):101–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Benrimoj SI, Werner JB, Raffaele C, et al. A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies. Pharm World Sci. 2008;30(2):147–53.PubMedCrossRefGoogle Scholar
  19. 19.
    Black J, Saini B, Wong K. The role of pharmacists in improving the management of sleep disorders in the community. Respirology. 2007;12(1):A24.Google Scholar
  20. 20.
    Tze-Min Ang K, Saini B, Wong K. Sleep health awareness in pharmacy undergraduates and practicing community pharmacists. J Clin Pharm Ther. 2008;33:641–52.PubMedCrossRefGoogle Scholar
  21. 21.
    Benrimoj SI, Gilbert A, Quintrell N, de Almeida Neto A. Non-prescription medicines: a process for standards development and testing in community pharmacies. Pharm World Sci. 2007;29:386–94.PubMedCrossRefGoogle Scholar
  22. 22.
    Schneider C, Everett W, Geelhoed E, Kendall P, Clifford R. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study. Ann Pharmacother. 2009;43:1512–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Puumalainen II, Peura SH, Kansanaho HM, Benrimoj SI, Airaksinen M. Progress in patient counselling practices in Finnish community pharmacies. Int J Pharm Prac. 2005;13:149–56.CrossRefGoogle Scholar
  24. 24.
    Berger K, Eickhoff C, Schulz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther. 2005;30:45–57.PubMedCrossRefGoogle Scholar
  25. 25.
    Granas AG, Haugli A, Horn AM. Smoking cessation advice provided in 53 Norwegian pharmacies. Int J Pharm Pract. 2004;12(4):179–84.CrossRefGoogle Scholar
  26. 26.
    Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists’ and pharmacist assistants’ practice in dealing with direct requests for analgesics. Int J Pharm Pract. 2002;10:23–9.CrossRefGoogle Scholar
  27. 27.
    Chua SS, Ramachandran CD, Paraidathathu TT. Response of community pharmacists to the presentation of back pain: a simulated patient study. Int J Pharm Pract. 2006;14:171–8.CrossRefGoogle Scholar
  28. 28.
    Watson MC, Hart J, Johnston M, et al. Exploring the supply of non-prescription medicines from community pharmacies in Scotland. Pharm World Sci. 2008;30(5):526–35.PubMedCrossRefGoogle Scholar
  29. 29.
    Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a “mystery shopper” study. Pharm World Sci. 2002;24(4):149–53.CrossRefGoogle Scholar
  30. 30.
    Pharmaceutical Society of Australia. Standards for the provision of pharmacy medicines and pharmacist only medicines in community pharmacy. Canberra: The Society, 2010.Google Scholar
  31. 31.
    Morgan M, Jenkins L, Risdale L. Patient pressure for referral for headache: a qualitative study of GPs referral behavior. Br J Gen Prac. 2007;57:29–35.Google Scholar
  32. 32.
    Charles J, Harrison C, Britt H. Insomnia. Aust Fam Physician. 2009;38(5):283.PubMedGoogle Scholar
  33. 33.
    Smith L, Bosnic-Anticevich S, Mitchell B, Krass I, Saini B, Armour C. Treating asthma with a self-management model of illness behavior in an Australian community pharmacy setting. Soc Sci Med. 2007;64:1501–11.PubMedCrossRefGoogle Scholar
  34. 34.
    O’Connor J, Seeto C, Saini B, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Pat Educ Couns. 2008;70:111–7.CrossRefGoogle Scholar
  35. 35.
    Espie C, MacMahon K, Kelly H. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavioral therapy for persistent insomnia in general practice. Sleep. 2007;30:574–84.PubMedGoogle Scholar
  36. 36.
    Alte D, Weitschies W, Ritter C. Evaluation of consultation in community pharmacies with mystery shoppers. Ann Pharmacother. 2007;41:1023–30.PubMedCrossRefGoogle Scholar
  37. 37.
    Svarstad B, Bultman D, Mount J. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age and busyness. J Am Pharm Assoc. 2004;44(1):22–5.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • Carly Kippist
    • 1
  • Keith Wong
    • 2
    • 3
    • 4
  • Delwyn Bartlett
    • 2
    • 3
    • 4
  • Bandana Saini
    • 1
    • 4
    Email author
  1. 1.Faculty of PharmacyUniversity of SydneySydneyAustralia
  2. 2.Woolcock Institute of Medical ResearchUniversity of SydneySydneyAustralia
  3. 3.Department of Respiratory and Sleep MedicineRoyal Prince Alfred HospitalSydneyAustralia
  4. 4.Centre for Integrated Research into the Understanding of Sleep, NHMRC funded Centre of Clinical and Research ExcellenceUniversity of SydneySydneyAustralia

Personalised recommendations